A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)
PHASE3
The primary objective of this study is to compare the effect of mitapivat v...
Status
Recruiting
Location
Weill Cornell Medical College/ New York Presbyterian
A Study to Compare the Pharmacokinetics and Safety of Mitapivat 100 mg Tablet Formulation With Mitapivat 2 × 50 mg Tablet Formulation in Healthy Adult Participants
PHASE1
The primary purpose of this study is to characterize and compare the pharma...
A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With α- or β-Non-Transfusion-Dependent Thalassemia
PHASE3
The primary objective of this study is to compare the effect of mitapivat v...
A Pharmacokinetic Study of Mitapivat in Participants With Moderate Hepatic Impairment Compared to Matched Healthy Control Participants With Normal Hepatic Function
PHASE1
The primary purpose of this study is to compare the pharmacokinetics (PK) o...